Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1998;77(Suppl 2):5–7. doi: 10.1038/bjc.1998.419

Assessing patients' needs and preferences in the management of advanced colorectal cancer.

K Redmond 1
PMCID: PMC2149720  PMID: 9579849

Abstract

Clinical decision-making in advanced cancer is a highly complex process. Many factors are thought to influence this process arguably the most important of these is the patient's own preference. Studies show that most patients want to be fully informed as to their diagnosis and involved in clinical decision-making. However, the attitudes of healthcare workers often preclude patient involvement. Studies have also shown that acceptability of chemotherapy for minimal therapeutic gain differs markedly between patients depending on factors such as age, gender and family status. It is clearly impossible to make decisions about what is best for patients without involving them in the decision-making process. Indeed, it could be argued that active patient participation actually simplifies this process.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen-Mersh T. G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994 Nov 5;344(8932):1255–1260. doi: 10.1016/s0140-6736(94)90750-1. [DOI] [PubMed] [Google Scholar]
  2. Blanchard C. G., Labrecque M. S., Ruckdeschel J. C., Blanchard E. B. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27(11):1139–1145. doi: 10.1016/0277-9536(88)90343-7. [DOI] [PubMed] [Google Scholar]
  3. Bremnes R. M., Andersen K., Wist E. A. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer. 1995 Nov;31A(12):1955–1959. doi: 10.1016/0959-8049(95)00513-7. [DOI] [PubMed] [Google Scholar]
  4. Cassileth B. R., Zupkis R. V., Sutton-Smith K., March V. Information and participation preferences among cancer patients. Ann Intern Med. 1980 Jun;92(6):832–836. doi: 10.7326/0003-4819-92-6-832. [DOI] [PubMed] [Google Scholar]
  5. Corner J., Wilson-Barnett J. The newly registered nurse and the cancer patient: an educational evaluation. Int J Nurs Stud. 1992 May;29(2):177–190. doi: 10.1016/0020-7489(92)90007-4. [DOI] [PubMed] [Google Scholar]
  6. Fallowfield L. J., Hall A., Maguire G. P., Baum M. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ. 1990 Sep 22;301(6752):575–580. doi: 10.1136/bmj.301.6752.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glimelius B., Hoffman K., Graf W., Haglund U., Nyrén O., Påhlman L., Sjödén P. O. Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol. 1995 Mar;6(3):267–274. doi: 10.1093/oxfordjournals.annonc.a059157. [DOI] [PubMed] [Google Scholar]
  8. Grahn G. Patient information as a necessary therapeutic intervention. Eur J Cancer Care (Engl) 1996 Mar;5(1 Suppl):7–8. [PubMed] [Google Scholar]
  9. McNeil B. J., Weichselbaum R., Pauker S. G. Fallacy of the five-year survival in lung cancer. N Engl J Med. 1978 Dec 21;299(25):1397–1401. doi: 10.1056/NEJM197812212992506. [DOI] [PubMed] [Google Scholar]
  10. McNeil B. J., Weichselbaum R., Pauker S. G. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med. 1981 Oct 22;305(17):982–987. doi: 10.1056/NEJM198110223051704. [DOI] [PubMed] [Google Scholar]
  11. O'Connor A. M. Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol. 1989;42(2):119–126. doi: 10.1016/0895-4356(89)90085-1. [DOI] [PubMed] [Google Scholar]
  12. Scheithauer W., Rosen H., Kornek G. V., Sebesta C., Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 1993 Mar 20;306(6880):752–755. doi: 10.1136/bmj.306.6880.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stiggelbout A. M., de Haes J. C., Kiebert G. M., Kievit J., Leer J. W. Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes. Med Decis Making. 1996 Apr-Jun;16(2):184–192. doi: 10.1177/0272989X9601600211. [DOI] [PubMed] [Google Scholar]
  15. Sutherland H. J., Llewellyn-Thomas H. A., Lockwood G. A., Tritchler D. L., Till J. E. Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med. 1989 May;82(5):260–263. doi: 10.1177/014107688908200506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thomsen O. O., Wulff H. R., Martin A., Singer P. A. What do gastroenterologists in Europe tell cancer patients? Lancet. 1993 Feb 20;341(8843):473–476. doi: 10.1016/0140-6736(93)90218-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES